<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4060">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03054064</url>
  </required_header>
  <id_info>
    <org_study_id>PHIND_CVA01</org_study_id>
    <nct_id>NCT03054064</nct_id>
  </id_info>
  <brief_title>Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA</brief_title>
  <official_title>Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parker Hannifin Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shepherd Center, Atlanta GA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheltering Arms Physical Rehabilitation Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rehabilitation Institute of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kessler Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Charles Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TIRR Memorial Hermann</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rusk Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Parker Hannifin Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of the Indego
      exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular
      Accident (CVA).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of individuals with hemiplegia due to CVA using the Indego measured through reported Subject Adverse Events and Serious Adverse Events</measure>
    <time_frame>2 weeks</time_frame>
    <description>Safety of individuals with hemiplegia due to CVA using the Indego measured through reported Subject Adverse Events and Serious Adverse Events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spasticity of bilateral upper and lower extremities measured with Modified Ashworth Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>Spasticity measured with Modified Ashworth Scale (MAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity measured by Functional Ambulation Category</measure>
    <time_frame>2 weeks</time_frame>
    <description>Activity measured by Functional Ambulation Category (FAC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait speed (without Indego) measured with 10 Meter Walk Test</measure>
    <time_frame>2 weeks</time_frame>
    <description>10 Meter Walk Test (MWT) without Indego to measure gait speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain measured with Face, Legs, Activity, Cry, Consolability Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain measured with Face, Legs, Activity, Cry, Consolability (FLACC) Scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cerebrovascular Accident (CVA)</condition>
  <condition>Stroke</condition>
  <condition>Hemiplegia</condition>
  <arm_group>
    <arm_group_label>All Enrolled Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All enrolled subjects will receive gait training with the Indego.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indego Exoskeleton</intervention_name>
    <description>Six study sessions including five Indego training sessions over two weeks.</description>
    <arm_group_label>All Enrolled Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Height 5'1&quot; to 6'3&quot; (acceptable height may vary by a few inches depending on femur
             length)

          -  Weight 250 pounds or less

          -  History of one sided ischemic or hemorrhagic stroke with resultant hemiparesis

          -  Manual Muscle Test (MMT) 4/5 in at least upper extremity

          -  No restrictions on time since stroke (acuity), but all subjects need to be cleared by
             MD for locomotor training

          -  No other brain abnormalities or neurological diseases/disorders

          -  Has not been diagnosed with more than one stroke

          -  Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within
             functional limits for safe gait

          -  Skin intact where interfaces with Indego device

          -  Modified Ashworth Scale (MAS) for spasticity 3 or less in the lower extremities

          -  Absence of complicating physical or mental conditions as determined by MD that would
             preclude the individual from safely participating in gait training

          -  Must be able to follow directions and communicate basic needs, demonstrated by a
             Mini- Mental State Exam (MMSE) score of 18 or greater

        Exclusion Criteria:

          -  Failure to meet all inclusion criteria

          -  Pregnancy

          -  Colostomy bag

          -  Uncontrolled/untreated hyper- or hypotension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ryan J Farris</last_name>
    <phone>(216) 896-3335</phone>
    <email>ryan.farris@parker.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cedars-Sinai Health System</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pamela Roberts</last_name>
      <email>pamela.roberts@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shepherd Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clare Hartigan, MPT</last_name>
      <email>clare_hartigan@shepherd.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Institute of Chicago (Shirley Ryan AbilityLab)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susan Deems-Dluhy</last_name>
      <email>sdluhy@ric.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kessler Foundation</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Nolan</last_name>
      <email>knolan@kesslerfoundation.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rusk Rehabilitation</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamara Bushnik</last_name>
      <email>tamara.bushnik@nyumc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Charles Hospital</name>
      <address>
        <city>Port Jefferson</city>
        <state>New York</state>
        <zip>11777</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunia Choudhury</last_name>
      <email>SuniaH.Choudhury@chsli.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>TIRR Memorial Hermann</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuo-Hsiu (James) Chang</last_name>
      <email>Shuo-hsiu.chang@uth.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheltering Arms Physical Rehabilitation Centers</name>
      <address>
        <city>Mechanicsville</city>
        <state>Virginia</state>
        <zip>23116</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amber Walter</last_name>
      <email>awalter@shelteringarms.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 22, 2017</lastchanged_date>
  <firstreceived_date>February 13, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Hemiplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
